CY1109418T1 - Διαμορφωση της παραγωγης του πνευμονοκοκκικου καψικου πολυσακχαριτη - Google Patents

Διαμορφωση της παραγωγης του πνευμονοκοκκικου καψικου πολυσακχαριτη

Info

Publication number
CY1109418T1
CY1109418T1 CY20091101008T CY091101008T CY1109418T1 CY 1109418 T1 CY1109418 T1 CY 1109418T1 CY 20091101008 T CY20091101008 T CY 20091101008T CY 091101008 T CY091101008 T CY 091101008T CY 1109418 T1 CY1109418 T1 CY 1109418T1
Authority
CY
Cyprus
Prior art keywords
polysakharite
pulmonic
copper
modification
production
Prior art date
Application number
CY20091101008T
Other languages
English (en)
Inventor
Jeffrey N Weiser
Original Assignee
The Children΄S Hospital Of Philadelphia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22699002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1109418(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Children΄S Hospital Of Philadelphia filed Critical The Children΄S Hospital Of Philadelphia
Publication of CY1109418T1 publication Critical patent/CY1109418T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Η εφεύρεση αναφέρεται σε μεθόδους διαμόρφωσης της παραγωγής καψικού πολυσακχαρίτη σε πνευμονόκοκκους όπως ο Streptococcus pneumoniae. Η εφεύρεση αναφέρεται περαιτέρω σε μεθόδους κατευνασμού των πνευμονοκοκκικών μολύνσεων στα ζώα, και σε μεθόδους αναγνώρισης αμφότερων των παραγόντων ικανών διαμόρφωσης των πνευμονοκοκκικών μολύνσεων στα ζώα. Το σχήμα (1) που περιλαμβάνει τα σχήματα lAi-1Αvi και 1Bi-1Bvi είναι μια σειρά εικόνων που δείχνουν την επίδραση της περιβαλλοντικής συγκέντρωσης οξυγόνου και διοξειδίου του άνθρακα στη μορφολογία αποικιών και το μέγεθος κάψουλας, όπως αξιολογείται χρησιμοποιώντας την αντίδραση Quellung.
CY20091101008T 2000-03-16 2009-09-28 Διαμορφωση της παραγωγης του πνευμονοκοκκικου καψικου πολυσακχαριτη CY1109418T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18984700P 2000-03-16 2000-03-16
EP01918754A EP1268844B1 (en) 2000-03-16 2001-03-16 Modulating production of pneumococcal capsular polysaccharide

Publications (1)

Publication Number Publication Date
CY1109418T1 true CY1109418T1 (el) 2014-08-13

Family

ID=22699002

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101008T CY1109418T1 (el) 2000-03-16 2009-09-28 Διαμορφωση της παραγωγης του πνευμονοκοκκικου καψικου πολυσακχαριτη

Country Status (19)

Country Link
US (1) US6642017B2 (el)
EP (2) EP1268844B1 (el)
JP (1) JP4856345B2 (el)
KR (3) KR20080081978A (el)
CN (2) CN101586143A (el)
AT (1) ATE437955T1 (el)
AU (2) AU2001245795B2 (el)
BR (1) BRPI0109293B8 (el)
CA (1) CA2403001C (el)
CY (1) CY1109418T1 (el)
DE (1) DE60139384D1 (el)
DK (1) DK1268844T3 (el)
ES (1) ES2330919T3 (el)
HK (1) HK1055448A1 (el)
IL (3) IL151772A0 (el)
MX (1) MXPA02009047A (el)
NZ (1) NZ521343A (el)
PT (1) PT1268844E (el)
WO (1) WO2001068903A1 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1268844B1 (en) * 2000-03-16 2009-07-29 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7718791B2 (en) * 2005-04-08 2010-05-18 Wyeth Llc Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
RU2460539C2 (ru) * 2006-10-10 2012-09-10 Вайет СПОСОБ ОЧИСТКИ ПОЛИСАХАРИДОВ Streptococcus pneumoniae 3 ТИПА (ВАРИАНТЫ)
WO2009059054A2 (en) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Bacteria strains an d bacteriocin produced therefrom
DK2379734T3 (en) * 2008-12-18 2018-04-23 Wyeth Llc Method for Controlling the Molecular Weight of Polysaccharide of Streptococcus Pneumoniae Serotype 19A
PL2385981T3 (pl) * 2008-12-18 2020-01-31 Wyeth Llc Sposób kontroli masy cząsteczkowej polisacharydów streptococcus pneumoniae z zastosowaniem węgla
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
US9975801B2 (en) 2014-07-31 2018-05-22 Corning Incorporated High strength glass having improved mechanical characteristics
WO2015169774A1 (en) * 2014-05-07 2015-11-12 Glaxosmithkline Biologicals S.A. Purification of secreted polysaccharides from s. agalactiae
US11097974B2 (en) 2014-07-31 2021-08-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
US10611664B2 (en) 2014-07-31 2020-04-07 Corning Incorporated Thermally strengthened architectural glass and related systems and methods
WO2017123573A2 (en) 2016-01-12 2017-07-20 Corning Incorporated Thin thermally and chemically strengthened glass-based articles
US11795102B2 (en) 2016-01-26 2023-10-24 Corning Incorporated Non-contact coated glass and related coating system and method
WO2019040818A2 (en) 2017-08-24 2019-02-28 Corning Incorporated GLASSES HAVING ENHANCED TEMPERATURE CAPABILITIES
TWI785156B (zh) 2017-11-30 2022-12-01 美商康寧公司 具有高熱膨脹係數及對於熱回火之優先破裂行為的非離子交換玻璃
EP3744829A4 (en) * 2018-01-22 2021-10-27 The Research Foundation For Microbial Diseases Of Osaka University MEDIUM FOR GROWING PNEUMOCOCCAL SAMPLES
CN114514115B (zh) 2019-08-06 2023-09-01 康宁股份有限公司 具有用于阻止裂纹的埋入式应力尖峰的玻璃层压体及其制造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
EP0804582A1 (en) * 1994-05-16 1997-11-05 The Uab Research Foundation $i(STREPTOCOCCUS PNEUMONIAE) CAPSULAR POLYSACCHARIDE GENES AND FLANKING REGIONS
EP1268844B1 (en) * 2000-03-16 2009-07-29 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide

Also Published As

Publication number Publication date
EP1268844A1 (en) 2003-01-02
ES2330919T3 (es) 2009-12-17
IL191962A0 (en) 2008-12-29
KR20080081978A (ko) 2008-09-10
AU4579501A (en) 2001-09-24
KR20080036656A (ko) 2008-04-28
DE60139384D1 (de) 2009-09-10
MXPA02009047A (es) 2005-04-19
US20030021811A1 (en) 2003-01-30
NZ521343A (en) 2005-03-24
CA2403001A1 (en) 2001-09-20
ATE437955T1 (de) 2009-08-15
IL151772A0 (en) 2003-04-10
CN101586143A (zh) 2009-11-25
PT1268844E (pt) 2009-11-03
IL151772A (en) 2009-12-24
CA2403001C (en) 2012-07-03
CN1429276A (zh) 2003-07-09
JP4856345B2 (ja) 2012-01-18
KR100942738B1 (ko) 2010-02-17
BRPI0109293B1 (pt) 2015-05-19
HK1055448A1 (en) 2004-01-09
EP1967591A2 (en) 2008-09-10
KR100914702B1 (ko) 2009-08-28
DK1268844T3 (da) 2009-11-16
JP2003531584A (ja) 2003-10-28
AU2001245795B2 (en) 2005-07-28
BRPI0109293B8 (pt) 2021-05-25
EP1967591A3 (en) 2008-12-03
BR0109293A (pt) 2003-06-10
KR20030040196A (ko) 2003-05-22
IL191962A (en) 2010-12-30
EP1268844A4 (en) 2006-03-29
WO2001068903A1 (en) 2001-09-20
US6642017B2 (en) 2003-11-04
EP1268844B1 (en) 2009-07-29
CN100529054C (zh) 2009-08-19

Similar Documents

Publication Publication Date Title
CY1109418T1 (el) Διαμορφωση της παραγωγης του πνευμονοκοκκικου καψικου πολυσακχαριτη
ATE410800T1 (de) Anordnung, umfassend einen ph-sensor und einen steckverbinder
PT1109787E (pt) Arilpiperazinas e sua utilizacao como inibidores de metaloproteinases
BR0207984A (pt) Inibidores de metaloproteinase
DE69809187D1 (de) Metalloproteinase-Inhibitoren
DE60135653D1 (de) Einkristalldiamant hergestellt durch cvd
DE69028903D1 (de) Ausgangsdatenpufferschaltung für integrierte Halbleiterschaltung
ATE390629T1 (de) Mikrophysiomessgerät
DK1535068T3 (da) Anordninger og fremgangsmåder til detektering af fostervand i vaginalsekreter
DE3852920T2 (de) Eingebrannte fassung für flachförmiges halbleitergehäuse.
ATE433963T1 (de) Fab-i inhibitoren
NO914217D0 (no) Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav
ATE359896T1 (de) Maschinenausführung
EA200400195A1 (ru) Способ репродукции вируса
DE3889584D1 (de) Ausgangspuffer für MOS-integrierte Halbleiterschaltung.
TW358099B (en) Process for the synthesis of crysteamine melaminylthioarsenate dihydrochloride or melarsomine dyhydro-chloride
DE69030433T2 (de) Herstellungsmethode für Halbleiterspeicher
DE50206549D1 (de) Auswerteschaltung und Signalverarbeitungsverfahren
DE60232358D1 (de) Magnetoresistive bitstruktur und verfahren zu ihrer herstellung
ID24130A (id) Campuran asam-formamidinasulfinik ii
DE69904925T2 (de) Ausgangshohlraumstruktur fur einen verstarker mit induktivem ausgang
NO904335D0 (no) Fenylsulfon-derivater.
DE29818720U1 (de) Einrichtung zur Erzeugung von thermisch verwertbaren Hackschnitzeln
TR200003084T2 (tr) Paroxetine askorbat
KR890015429A (ko) Mos형 반도체소자의 제조방법